Tiludronate use while Breastfeeding
Drugs containing Tiludronate: Skelid
Medically reviewed by Drugs.com. Last updated on Jun 19, 2018.
Tiludronate Levels and Effects while Breastfeeding
Summary of Use during Lactation
Because no information is available on the use of tiludronate during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. However, absorption of tiludronate by a breastfed infant is unlikely.
Drug Levels
Tiludronate is highly bound to calcium and is poorly absorbed orally (average in adults 6% on an empty stomach, 0.6% with food), so absorption of tiludronate by a breastfed infant is unlikely.
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
Tiludronate Identification
Substance Name
Tiludronate
CAS Registry Number
89987-06-4
Drug Class
Breast Feeding
Lactation
Bisphosphonates
Bone Density Conservation Agents
Diphosphonates
Administrative Information
LactMed Record Number
724
Disclaimer
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about tiludronate
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Drug class: bisphosphonates
- FDA Alerts (3)
Consumer resources
Other brands: Skelid
